MID2 and breast cancer: Furthermore, CALM2 was overexpressed in tumor tissues and correlated with poorer prognosis in patients with breast cancer (Figure S4.C, D) and TNBC (Fig. 7G and H) patients in the TCGA [39] and Metabric [40] databases, suggesting that CALM2 gene expression might also account for the malignant behaviors of TRIM1-269aa.